Showing 911-920 of 7665 results for "".
Weighing the Evidence: COVID Shots and the Skin
https://practicaldermatology.com/topics/practice-management/weighing-the-evidence-covid-shots-and-the-skin/23576/Cosmetic Surgery Forum faculty members sound off on skin reactions after COVID-19 vaccination.Safe and Careful
https://practicaldermatology.com/columns/editors-message/safe-and-careful/23563/Cosmetic Surgery Forum 2021 will open to vaccinated attendees and exhibitors.Checkpoint Blockade for Advanced cSCC: Exploring Newer Options
https://practicaldermatology.com/topics/skin-cancer-photoprotection/checkpoint-blockade-for-advanced-cscc-exploring-newer-options/23487/Two newer systemic options on the market provide hope in the fight against advanced cutaneous squamous cell carcinoma.Catch The Wave Of The Future
https://practicaldermatology.com/topics/practice-management/catch-the-wave-of-the-future/23478/Clearwave’s patient engagement platform may help create zero-contact offices.Frax Pro and CoolSculpting Elite Launch, Antibiotic Resistance in Rosacea, Thriving in Aesthetics Rolls Out
https://practicaldermatology.com/series/dermwire-tv/frax-pro-and-coolsculpting-elite-launch-antibiotic-resistance-in-rosacea-thriving-in-aesthetics-rolls-out/19896/The majority of rosacea patients have never heard of antibiotic resistance, a new survey reported by the National Rosacea Society finds. Candela’s Frax Pro system is now available, featuring Frax 1550 and the novel Frax 1940 applicators. Allergan Aesthetics, an AbbVie company, is launching CoolSculpGetting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.Snapshot: The Percentage of Dermatology Offices Open During the COVID-19 Pandemic
https://practicaldermatology.com/topics/practice-management/snapshot-the-percentage-of-dermatology-offices-open-during-the-covid-19-pandemic/23404/A survey of practices in two states sheds light on the impact of the novel coronavirus.RIP Clarisonic, Hello New Contenders
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/rip-clarisonic-hello-new-contenders/23354/CSF faculty share top picks for at-home beauty devices.Management of Atopic Dermatitis During the COVID-19 Pandemic
https://practicaldermatology.com/topics/atopic-dermatitis/management-of-atopic-dermatitis-during-the-covid-19-pandemic/23322/There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.DermWireTV: AAD Virtual Data Highlights, Cynosure Consumer Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aad-virtual-data-highlights-cynosure-consumer-data/19818/The American Academy of Dermatology 2020 VMX Virtual Conference shines a light on fresh data from UCB, Leo Pharma, Lilly and Dermira, and Soliton. Cassiopea reports long-term data for Clascoterone. Zilxi from Menlo and Foamix approved for rosacea. Cynosure reports positive cosmetic consumer outlook